Publications by authors named "Zujiang Yu"

Claim this Profile
A
A machine learning model for mortality prediction in patients with severe fever with thrombocytopenia syndrome: a prospective, multicenter cohort study.
Yanan Liu, Lei Fan, Wencai Wang, Hongxuan Song, Zhenghua Zhang, Xinyue Zhang, Zujiang Yu, Yuliang Liu

Emerg Microbes Infect· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in the oral microbiome detected during long-term follow-up of COVID-19 recovered patients.
Qiong Wang, Feng Gao, Di Zhu, Hongyan Ren, Yakun Xu, Zujiang Yu

J Infect Public Health· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon.
Jianxia Dong, Shan Ren, Pengxuan Wu, Haitian Yu, Xinyue Meng, Zujiang Yu, Xinyue Chen

Hepatol Int· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic insights into post-translational modifications in hepatic fibrosis: pathogenic roles and therapeutic potentials.
Xiwen Bai, Zhihan Liu, Xianbin Li, Ranran Sun, Zujiang Yu

J Transl Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations in the serum metabolome in patients with the COVID-19 Omicron variant and in recovered cases.
Feng Gao, Daming Wang, Lihua Zuo, Junyi Sun, Bowen Dong, Haiyu Wang, Zujiang Yu

PLoS One· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic alterations of oral fungal microbiota in Omicron infected patients.
Yarong Ma, Shanshuo Liu, Guizhen Zhang, Liwen Liu, Junyi Sun, Haiyu Wang, Zujiang Yu

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ablation of hepatocellular carcinoma at high-risk sites based on nanosecond pulsed electric field.
Gang Dong, Shan-Shuo Liu, Zhen-Guo Liu, Ying Sun, Ya-Wen Zou, Zu-Jiang Yu

Hepatobiliary Pancreat Dis Int· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rice-derived recombinant human serum albumin as an alternative to human plasma for patients with decompensated liver cirrhosis: a randomised, double-blind, positive-controlled and non-inferiority trial.
Junqi Niu, Yanhang Gao, Guiqiang Wang, Zhijie Qin, Cuisong Wu, Zujiang Yu, Yue Chen

Gut· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finotonlimab (PD-1 inhibitor) plus bevacizumab (bevacizumab biosimilar) as first-tier therapy for late-stage hepatocellular carcinoma: a randomized phase 2/3 trial.
Chuanhua Zhao, Yanqiao Zhang, Gang Wang, Jinfang Zheng, Weiqing Chen, Zujiang Yu, Yuwen Wang, Yu Wang

Signal Transduct Target Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chiglitazar in MASLD with hypertriglyceridemia and insulin resistance: A phase II, randomized, double-blind, placebo-controlled study.
Yameng Sun, Cuisong Wu, Guijie Xin, Bihui Zhong, Xiaofeng Wu, Yufeng Gao, Yueyong Zhu, Zujiang Yu, Yuemin Nan, Yue Li, Chaohui Yu

Hepatology· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance and hypothetical clinical impact of an mNGS-based machine learning model for antimicrobial susceptibility prediction of five ESKAPEE bacteria.
Yaoguang Li, Sizhen Liu, Peng Han, Jun Lei, Huifen Wang, Zujiang Yu

Microbiol Spectr· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
cfDNA methylation detection as potential liquid biopsy of multiple organ injury in myocarditis patients.
Yangchao Zhao, Yujia Wang, Xi Zhao, Xin Zhang, Haoyan Wang, Zujiang Yu

Clin Epigenetics· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expected 8-Week Prenatal vs 12-Week Perinatal Tenofovir Alafenamide Prophylaxis to Prevent Mother-to-Child Transmission of Hepatitis B Virus: A Multicenter, Prospective, Open-Label, Randomized Controlled Trial.
Qing-Lei Zeng, Yi-Hua Zhou, Xiao-Ping Dong, Ji-Yuan Zhang, Guang-Ming Li, Ru-Yue Chen, Chang-Yu Sun, Zu-Jiang Yu

Am J Gastroenterol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Antiviral Efficacy and Safety of Azvudine in Hospitalized SARS-CoV-2 Infected Patients with Liver Diseases Based on a Multicenter, Retrospective Cohort Study.
Junyi Sun, Mengzhao Yang, Guanyue Su, Ling Wang, Xiaobo Hu, Yiqiang Yuan, Zujiang Yu

Adv Sci (Weinh)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma methylated as a non-invasive biomarker for diagnostic modeling of hepatocellular carcinoma.
Weiwei Zhu, Huifen Wang, Yudie Cai, Jun Lei, Jia Yu, Zujiang Yu

Front Med (Lausanne)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The tongue coating microbiome is perturbed in atrial fibrillation and partly normalized after catheter ablation.
Ling Wang, Na Li, Yuchen Zheng, Qiong Huang, Guangying Cui, Yu He, Yumei Sun, Zujiang Yu, Yiqiang Yuan

Front Microbiol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, real-world cohort study: effectiveness and safety of Azvudine in hospitalized COVID-19 patients with pre-existing diabetes.
Yongjian Zhou, Zecheng Yang, Shixi Zhang, Donghua Zhang, Hong Luo, Zujiang Yu

Front Endocrinol (Lausanne)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19.
Bohan Jia, Junyi Sun, Di Zhu, Ling Wang, Xiaobo Hu, Haiyu Wang, Zujiang Yu

Sci Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the efficacy and mechanisms of azvudine in elderly patients with malignant tumors complicated by COVID-19.
Ranran Sun, Yihang Song, Zhe Li, Daming Wang, Zujiang Yu

Acta Pharm Sin B· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19 and pre-existing diabetes.
Guanyue Su, Silin Li, Donghua Zhang, Yongjian Zhou, Ling Wang, Yiqiang Yuan, Jiyuan Xing, Zujiang Yu

iScience· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness and safety of oral Azvudine versus Paxlovid for COVID-19 in patients with kidney disease: a multicenter, retrospective, cohort study.
Benchen Rao, Daming Wang, Mengzhao Yang, Chunyu Zhao, Ming Cheng, Zujiang Yu

BMC Infect Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort study.
Haiyu Wang, Guangying Cui, Ming Cheng, Tuerganaili Aji, Guotao Li, Yiqiang Yuan, Guanyue Su, Zujiang Yu

Signal Transduct Target Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness and safety of azvudine in hospitalized patients with SARS-CoV-2 infection: A multicenter, retrospective cohort study.
Zhigang Ren, Mengzhao Yang, Guanyue Su, Guowu Qian, Yiqiang Yuan, Jia Yu, Haiyu Wang, Zujiang Yu

J Infect· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retraction Note: Circular RNA MYLK promotes hepatocellular carcinoma progression by increasing Rab23 expression by sponging miR-362-3p.
Zhiqin Li, Yushu Hu, Qinglei Zeng, Hongyan Wang, Jingya Yan, Zujiang Yu

Cancer Cell Int· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling microbial dynamics in lung adenocarcinoma and adjacent nontumor tissues: insights from nicotine exposure and diverse clinical stages via nanopore sequencing technology.
Kangli Yang, Shuaifeng Wang, Zheng Ding, Kai Zhang, Weiwei Zhu, Zujiang Yu

Front Cell Infect Microbiol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis